Alzheimers Parkinsons ALS

🧠 Stay ahead with the latest in science, nutrition, and wellness by subscribing to Dr. Perlmutter’s newsletter at: www.drperlmutter.com. ✉️🌱In this compell...

Plant-based diets in general, and certain plant foods in particular, may be used to treat Parkinson's disease—in part, by boosting L-DOPA levels.

Fava bean sprouts and soy nuts are put to the test for Parkinson’s disease as natural sources of L-dopa.

Since Parkinson’s is caused by a dopamine deficiency in the brain, what if you ate foods rich in the dopamine precursor levodopa?

New evidence links antidepressants to faster dementia progression, fractures, and mortality—raising urgent questions about misdiagnosis and medical harm.

#ParkinsonsDisease #VitaminB6 #B6Toxicity #SupplementsAndPD #MTHFR #FunctionalNeurology #NeuropathyAwareness #parkinsonsawareness #NervousSystemHealth #B6Sid...

Find light in the darkness of Alzheimer's and Dementia. Feel better in 5 weeks or get fully reimbursed. See how EVY LIGHT® could help you!

🧠 Stay ahead with the latest in science, nutrition, and wellness by subscribing to Dr. Perlmutter’s newsletter at: www.drperlmutter.com. ✉️🌱I’m thrilled to...

An interesting new article suggests value of creatine supplementation in Alzheimer's disease

#Parkinsons #TheParkinsonsPlan #EnvironmentalHealth #Neuroscience #PreventParkinsonsParkinson’s disease is rising faster than ever before — with 90,000 new U...

Exposing the pain industry and the forgotten treatments for pain

Share This Sign up at: ParkinsonsDisease.blog About Jonathan Sackner-Bernstein, MD Dr. Sackner-Bernstein shares his pursuit of conquering Parkinson's, using expertise developed as Columbia University faculty, FDA senior official, DARPA insider and witness to the toll of PD. Dr. S-B’s Linkedin page RightBrainBio, Inc. was incorporated in 2022 to develop tranformative therapies for people with Parkinson's.

Plant-based diets in general and certain plant foods in particular may be used to successfully treat Parkinson's disease in part by boosting L-DOPA levels. W...

The Latest in Nutrition Research

NutritionFacts.org is a science-based nonprofit organization founded by Michael Greger, M.D. FACLM, that provides free updates on the latest in nutrition research via bite-sized videos, blogs, podcasts, and infographics. We are strictly non-commercial, without any sponsors, ads, brand partnerships, or paid subscriptions. More than 2,000 videos on virtually every aspect of healthy eating are available online, and new videos and blogs are uploaded weekly. Our reach is global, with a Spanish-language site, Chinese platforms, and video captions in many languages. NutritionFacts.org is a labor of love—a tribute to Dr. Greger’s grandmother whose own life was saved by improving her diet. Videos-of-the-day are released Monday, Wednesday, Friday, and podcasts are released Thursday. Our videos are always ad-free. If you would like to support our work, visit https://nutritionfacts.org/donate/.

AMG Charitable Foundation, Tackle ALS, the ALS Association, ALS Finding a Cure, the Muscular Dystrophy Association, ALS ONE, the Arthur M Blank Family Foundation, I AM ALS, Tambourine ALS Collaborative, and other community fundraising initiatives and donors. Study drug and partial regimen-related fu …

BACKGROUND Preclinical studies suggest that creatine monohydrate (CrM) improves cognition and Alzheimer's disease (AD) biomarkers. However, there is currently no clinical evidence demonstrating the ...

A just-published study provides new insight into creatine in the context of Alzheimers. For all the references/articles I cited, article is coming tomorrow!#...

Parkinson's New Zealand provides information, education and support to people living with Parkinson's, care partners and healthcare professionals. Parkinson's is a progressive neurological condition which affects over 12,000 New Zealanders. Although it cannot be cured, treatment is available.

Dr Matthew Phillips is an expert on ketosis and in this presentation he discusses recent studies and the impact ketosis has on Parkinson's. This very inform...

This channel is dedicated to helping Persons with Parkinson's Disease to become Parkinson's Warriors fighting their disease wielding the weapon of knowledge about PD and the impact that it has on daily living. Book 1:1 consultation with a Parkinson's Disease Expert here: https://clarity.fm/pdeducation Explore channel memberships here: YouTube: https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join Patreon: https://www.patreon.com/pdeducation If you have products that you would like for me to review on the channel please send them here: Parkinson's Disease Education P.O. Box 1678 Broken Arrow, OK 74013

PDF | AMPT (alpha-methyl-para-tyrosine) is an inhibitor of tyrosine hydroxylase, the rate-limiting enzyme in dopamine biosynthesis. In clinical... | Find, read and cite all the research you need on ResearchGate

Because the data say RB-190 should work.

Following reports of low striatal dopamine content in Parkinson’s disease, levodopa was shown to rapidly reverse hypokinesis, establishing the model of disease as one of dopamine deficiency. Dopaminergic therapy became standard of care, yet it failed to reverse the disease, suggesting the understanding of disease was incomplete. The literature suggests the potential for toxicity of dopamine and its metabolites, perhaps more relevant given the recent evidence for elevated cytosolic dopamine levels in the dopaminergic neurons of people with Parkinson’s. To understand the relevance of these data, multiple investigations are reviewed that tested dopamine reduction therapy as an alternative to dopaminergic agents. The data from use of an inhibitor of dopamine synthesis in experimental models suggest that such an approach could reverse disease pathology, which suggests that cytosolic dopamine excess is a primary driver of disease. These data support clinical investigation of dopamine reduction therapy for Parkinson’s disease. Doing so will determine whether these experimental models are predictive and this treatment strategy is worth pursuing further. If clinical data are positive, it could warrant reconsideration of our disease model and treatment strategies, including a shift from dopaminergic to dopamine reduction treatment of the disease.

Right Brain Bio is developing a data-driven treatment for Parkinson's - one so revolutionary that it will transform disease understanding and treatment.

Dr. Gilbert discusses the seven new medications that were approved to treat Parkinson’s disease motor symptoms since 2017

Exploring Ivermectin’s Neuromodulatory Role in Enhancing Parkinson’s Treatment

Can Ivermectin play a key role in treating Parkinson's Disease? Two peer-reviewed papers—one by Warnecke et al. (2020) and another by Wa...

Cerebral glucose and insulin metabolism is impaired in Alzheimer's disease (AD). Ketones provide alternative energy. Will medium chain triglyceride (MCT) oil, a nutritional source of ketones, impact cognition in AD? This was a 6‐month randomized, ...